Hunt: England to be technology ‘leader’
November 15, 2012Medical Communications, Sales and Marketing Jeremy Hunt, NHS, telehealth
Technology is to free 100,000 people next year from what health secretary Jeremy Hunt calls the ‘constant merry-go-round’ of doctors’ …
Lundbeck opens first Asian manufacturing plant
November 14, 2012Manufacturing and Production China, Lundbeck
Lundbeck has officially opened its first manufacturing facility in China and says it plans to launch three new drugs there …
Germany dismisses Seroquel XR
November 14, 2012Sales and Marketing AstraZeneca, FDA, Germany, Seroquel XR
AstraZeneca has received another dent in its international attempts to keep the money-spinning antipsychotic Seroquel going in a new form. …
No specific targets in NHS mandate
November 14, 2012Sales and Marketing CCGs, NHS, commissioning
The government has given the first public directive to the nascent NHS Commissioning Board, which assumes its new responsibilities from …
Eugene Washington appointed to J&J Board of directors
November 13, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eugene Washington, J&J, JJ
Dr Eugene Washington has been appointed to the Board of directors at Johnson & Johnson. Washington serves as vice chancellor …
AstraZeneca signs genome deal
November 13, 2012Research and Development, Sales and Marketing AstraZeneca, Foundation, SMIP
AstraZeneca has signed a genomic profiling agreement with US molecular information company Foundation Medicine. The collaboration will use its FoundationOne …
EFCG calls for mandatory inspection of API plants
November 13, 2012Manufacturing and Production API, EFCG, EU, FMD
The European Fine Chemicals Group (EFCG) has called for all active pharmaceutical ingredient (API) manufacturing facilities to undergo mandatory inspections. …
Hospira on track to return propofol to market
November 13, 2012Manufacturing and Production Ball, Hospira, Teva
Shortages of the short-acting anaesthetic propofol in the US could be helped by the return to market of a generic …
NHS Commissioning Board appoints Patients and Information directors
November 13, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Coulthard, NHS, NHS Commissioning Board
The NHS Commissioning Board has made a series of appointments to complete its director-level recruitment to the Patients & Information …
Pharma can help NHS transition, says partnership leader
November 13, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CCGs, Conference, NHS, PCT
A new ABPI team is now ready to help the pharmaceutical industry forge partnerships with the NHS, even as the …
Patients ‘shut out’ of drug price talks
November 13, 2012Sales and Marketing Cancer, NHS, NICE, VBP, prostate
Patients are being excluded from the negotiations between government and the pharma industry on the introduction of Value-Based Pricing (VBP).That …
Pfizer and GSK end agreements
November 12, 2012Research and Development, Sales and Marketing Auxilium, GSK, Pfizer, Xenoport
Pfizer and GlaxoSmithKline are both handing back the rights to two drugs in April 2013 as part of the termination …
Havas Health launches new Global Agency Group, Havas Lynx
November 12, 2012Medical Communications
Euro RSCG Life 4D and Creative Lynx join to form new Global Brand for the next era in Health and …
Contract research news in brief
November 12, 2012Research and Development Bay Bioanalytical Laboratory, Bioclinica, Charles River, ICON, Pacific BioLabs, Quintiles, Vital River
Acquisitions for Charles River and Pacific BioLabs, a new contract for Bioclinica plus updates from Icon and Quintiles.
immatics appoints Peter Chambré as chairman
November 12, 2012Manufacturing and Production, Research and Development, Sales and Marketing Peter Chambre, immatics
Biotech development firm immatics has announced the appointment of Peter Chambré as chairman of the Board. Chambré has had extensive …
NHS: pharma needs to help more
November 12, 2012Sales and Marketing CCGs, NHS, pharma
A variety of senior figures in public health set out how they want the pharma industry to do more to …
Copper could replace precious metals in pharma production
November 9, 2012Manufacturing and Production Sweden, copper, manufacturing
Non-precious metals such as copper could be used as catalysts in pharmaceuticals production, replacing precious metals that are expensive and …
GSK guilty of off-label promotion
November 9, 2012Medical Communications, Sales and Marketing GSK, PMCPA, Revolade
GlaxoSmithKline has been found to have breached three clauses in the ABPI Code of Practice following a complaint from a …
Pharma treated as though ‘selling cyanide’
November 9, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, Stephen Whitehead
APBI chief executive Stephen Whitehead claimed that pharma companies are sometimes made to feel as though they are manufacturing poison …
Astellas appoints VP of Scientific and Medical Affairs
November 9, 2012Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Jeffrey Bloss
Astellas has announced Jeffrey Bloss has joined the company as vice president of its Scientific and Medical Affairs (ASMA) division. …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
